Invesco Ltd. Takeda Pharmaceutical CO LTD Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $667,888 - $720,340	43,710 New	43,710 $720,000
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $149,222 - $334,001	-11,658 Reduced 25.76%	33,601 $436,000
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $63,054 - $72,234	-4,806 Reduced 9.6%	45,259 $635,000
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $677,880 - $768,497	50,065 New	50,065 $717,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $1.08 Million - $1.34 Million	-64,209 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $31,234 - $34,792	-1,934 Reduced 2.92%	64,209 $1.11 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $56,604 - $69,952	-3,414 Reduced 4.91%	66,143 $1.17 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $1.16 Million - $1.5 Million	69,557 New	69,557 $1.42 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.